"10.1371_journal.pone.0137345","plos one","2015-09-21T00:00:00Z","Jie Liu; Lijuan Wang; Feifei Zhao; Serena Tseng; Cyndhavi Narayanan; Lei Shura; Stephen Willingham; Maureen Howard; Susan Prohaska; Jens Volkmer; Mark Chao; Irving L Weissman; Ravindra Majeti","Institute for Stem Cell Biology and Regenerative Medicine and the Ludwig Cancer Center, Stanford University School of Medicine, Stanford, California, United States of America; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California, United States of America","Conceived and designed the experiments: JL LJW FFZ ST CN LS SW MH SP JV ILW RM. Performed the experiments: JL LJW FFZ ST CN LS. Analyzed the data: JL LJW FFZ ST CN LS SW MH SP JV ILW RM. Contributed reagents/materials/analysis tools: JL LJW FFZ ST CN LS MC. Wrote the paper: JL ILW RM.","JL, RM, and ILW have filed International Patent Application WO 2011/143624 A2 entitled ‘Humanized and chimeric monoclonal antibodies to CD47’. JL, RM, ILW, SW, JV, MH, and SP have filed U.S. Patent Application number PCT/US2014/018743 entitled ‘Methods for achieving therapeutically effective doses of anti-CD47 agents’. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","09","Jie Liu","JL",13,TRUE,12,6,12,3,TRUE,TRUE,FALSE,0,NA,FALSE
